CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms ...Middle East

HONG KONG, Dec. 7, 2023 /PRNewswire/ -- A randomised, double-blind, placebo-controlled trial (RECOVERY STUDY) conducted by The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and Microbiota I-Center (MagIC) showed that an oral microbiome microencapsulated...

Hence then, the article about cu medicine study published in the lancet infectious diseases concludes that a novel oral microencapsulated live bacteria consortia sim01 alleviates long covid symptoms was published today ( Friday 08/12/2023 - 05:44 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms )

Also on site :

• 'The chances of you living 50 years are very small': Theoretical physicist explains why humanity likely won't survive to see all the forces unified
• The Strokes End Coachella Performance With Video Montage Condemning U.S. and Israeli Bombings in Iran and Gaza
• FBI, DOJ scrambling to rebuild after being depleted by resignations and firings